Aspen Group Reports 13% Increase in Revenue to $76.7 million for Fiscal Year 2022

Fourth Quarter 2022 Highlights

• Diligent corporate overhead management drives sequential decline in G&A
• Narrowed net loss to $(2.1) million from $(2.3) million
• Adjusted EBITDA, a non-GAAP financial measure, increased to $0.5 million compared to $(1.3) million in third quarter demonstrating leverage in the business model
  
  

NEW YORK, July 19, 2022 (GLOBE NEWSWIRE) -- Aspen Group, Inc. (NASDAQ:ASPU) ("AGI"), an education technology holding company, today announced financial results for its fourth quarter and fiscal year ended April 30, 2022.

Fourth Quarter and Full Fiscal Year 2022 Summary Results

	Three months ended April 30,								For the Years Ended April 30,
$ in millions, except per share data		2022				2021				2022				2021
Revenue	$	19.4			$	19.1			$	76.7			$	67.8
Gross Profit1	$	10.3			$	9.9			$	39.6			$	36.9
Gross Margin (%)1		53	%			52	%			52	%			54	%
Net Income (Loss)	$	(2.1	)		$	(2.3	)		$	(9.6	)		$	(10.4	)
Earnings (Loss) per Share	$	(0.08	)		$	(0.09	)		$	(0.38	)		$	(0.44	)
EBITDA2	$	(0.8	)		$	(1.4	)		$	(5.1	)		$	(6.0	)
Adjusted EBITDA2	$	0.5			$	0.6			$	(1.0	)		$	1.3

<sup>_______________________                                                                                         

1</sup> GAAP gross profit calculation includes marketing and promotional costs, instructional costs and services, and amortization expense of $0.5 million and $0.4 million, and $1.8 million and $1.4 million, for the three months and years ended April 30, 2022 and 2021, respectively.

² Non-GAAP financial measures. See reconciliations of GAAP to non-GAAP financial measures under "Non-GAAP–Financial Measures" starting on page 5.

"Judicious control of marketing expenses in the fourth quarter led to a narrower net loss, positive Adjusted EBITDA and reduced our cash burn without compromising our ability to achieve our revenue target for the fourth quarter," said Michael Mathews, Chairman and CEO of AGI. "This performance demonstrates the leverage in our business model and our ability to improve our operating results with controlled spending. In the fourth quarter, we reduced our marketing spend sequentially by $1.0 million to ensure sufficient collateral for a surety bond requested by the State of Arizona. While this reduced enrollments in the fourth quarter, our USU MSN-FNP program was our fastest growing program in the quarter, demonstrating the demand for this high LTV program.

"Our business plans reflect future growth primarily from our new pre-licensure campuses and USU MSN-FNP program, which we believe will offset the near-term absence of core semester starts at the Arizona pre-licensure campuses. More than ever, our country recognizes the critical necessity to replace nurses who have left the field, and the need to grow the nursing population to meet the expected demand of future demographic trends. In addition, more FNPs are needed to meet our country's impending doctor shortage. Aspen Group is well-positioned to benefit from these long-term macro trends."

Fiscal Q4 2022 Financial and Operational Results (compared to Fiscal Q4 2021)

Revenue increased to $19.4 million compared to $19.1 million. Aspen University's (AU) revenue, which includes the high LTV BSN Pre-Licensure program, accounted for 66%, or $12.8 million, versus 70%, or $13.3 million of consolidated revenue. United States University (USU) revenue, which includes the high LTV MSN-FNP program, accounted for 34%, or $6.6 million, versus 30%, or $5.7 million, of consolidated revenue.

GAAP gross profit increased 4% to $10.3 million compared to $9.9 million. Gross margin was 53% compared to 52%. AU gross margin remained flat at 52% of AU revenue, and USU gross margin was 61% versus 57% of USU revenue.



AU instructional costs and services represented 27% of AU revenue, and USU instructional costs and services represented 27% of USU revenue. AU marketing and promotional costs represented 18% of AU revenue, while USU marketing and promotional costs represented 11% of USU revenue.

Net loss and net loss per share were ($2.1) million and ($0.08), respectively, compared to ($2.3) million and ($0.09), respectively. AU generated net income of $1.5 million versus $1.4 million, and USU generated net income of $1.3 million versus $1.0 million. AGI corporate incurred a net loss of ($5.0) million as compared to ($4.7) million.



EBITDA, a non-GAAP financial measure, was ($0.8) million and (4%) margin, respectively, compared to EBITDA of ($1.4) million and (8%) margin, respectively. AU generated EBITDA of $2.2 million and 17% margin as compared to $2.2 million and 16% margin. USU generated EBITDA of $1.5 million and 22% margin, as compared to $1.1 million and 19% margin. AGI corporate incurred EBITDA of ($4.5) million as compared to ($4.7) million.

Adjusted EBITDA, a non-GAAP financial measure, was $0.5 million and 3% margin, respectively, compared to Adjusted EBITDA of $0.6 million and 3% margin, respectively. AU generated Adjusted EBITDA of $2.5 million and 20% margin, as compared to $2.6 million and 20% margin. USU generated Adjusted EBITDA of $1.7 million and 26% margin as compared to $1.4 million and 24% margin. AGI corporate incurred Adjusted EBITDA of ($3.7) million as compared to ($3.3) million.

Fiscal Year 2022 Full Year Financial and Operational Results (versus Fiscal Year 2021)

Revenue increased 13% to $76.7 million compared to $67.8 million. AU revenue, which includes the high LTV BSN Pre-Licensure program, accounted for 68%, or $51.8 million, versus 71%, or $47.9 million of consolidated revenue. USU revenue, which includes the high LTV MSN-FNP program, accounted for 32%, or $24.9 million, versus 29%, or $19.9 million.

GAAP Gross profit increased by 7% to $39.6 million, or 52% gross margin, versus $36.9 million, or 54% gross margin. AU gross margin represented 51% versus 55% of AU revenue, and USU gross margin remained flat at 58% of USU revenue.

AU instructional costs and services represented 25% of AU revenue, while USU instructional costs and services represented 26% of USU revenue. AU marketing and promotional costs represented 20% of AU revenue, while USU marketing and promotional costs represented 16% of USU revenue.

Net loss was ($9.6) million and net loss per basic share of ($0.38), versus ($10.4) million and ($0.44) per share. AU generated $6.1 million of net income compared to $7.3 million, and USU generated $3.8 million of net income compared to $2.9 million. AGI corporate incurred a net loss of ($19.5) million compared to ($20.7) million.

EBITDA, a non-GAAP financial measure, was ($5.1) million and (7%) margin, as compared to EBITDA of ($6.0) million and (9%) margin. Adjusted EBITDA, a non-GAAP financial measure, was ($1.0) million and (1%) margin, compared to Adjusted EBITDA of $1.3 million and 2% margin.

AU generated EBITDA of $9.3 million and 18% margin, and Adjusted EBITDA of $10.0 million and 19% margin. USU generated EBITDA of $4.2 million and 17% margin, and Adjusted EBITDA of $4.9 million and 20% margin. AGI corporate incurred EBITDA of ($18.6) million and Adjusted EBITDA of ($15.9) million.

Operating Metrics

New student enrollments at AU decreased 37% year-over-year and at USU by 11% year-over-year. New student enrollments were primarily impacted by the enrollment stoppage at our Phoenix pre-licensure campuses, and the reduction in marketing spend by $1 million over the prior quarter.

New student enrollments for the past five quarters are shown below:

		New Student Quarterly Enrollments
		Q4'21			Q1'22			Q2'22			Q3'22			Q4'22
Aspen University		1,593			1,601			1,750			1,301			1,010
USU		589			675			630			481			525
Total		2,182			2,276			2,380			1,782			1,535

New student enrollments, bookings and ARPU for Q4'22 versus Q4'21 are shown below:

	Fourth Quarter Bookings1 and Average Revenue Per Enrollment (ARPU)1
	Q4'21 Enrollments		Q4'21 Bookings			Q4'22 Enrollments		Q4'22 Bookings
			(in millions)					(in millions)
Aspen University	1,593		$	21.7		1,010		$	12.4
USU	589		$	10.5		525		$	9.3
Total	2,182		$	32.2		1,535		$	21.7
ARPU				14,751					14,145

____________________

¹ "Bookings" are defined by multiplying Lifetime Value (LTV) by new student enrollments for each operating unit. "Average Revenue Per Enrollment" (ARPU) is defined by dividing total Bookings by total new student enrollments for each operating unit.

AGI's active degree-seeking student body at AU and USU, declined 4% year-over-year to 13,334 from 13,886. AU's total active student body decreased by 8% year-over-year to 10,225 from 11,117. On a year-over-year basis, USU's total active student body grew by 12% to 3,109 from 2,769. The chart below shows five quarters of active student body results.

Students seeking nursing degrees were 11,522, or 86% of total active students at both universities. Of the students seeking nursing degrees, 9,562 are RNs studying to earn an advanced degree, including 6,672 at Aspen University and 2,890 at USU. In contrast, the remaining 1,960 nursing students are enrolled in Aspen University's BSN Pre-Licensure program in the Phoenix, Austin, Tampa, Nashville and Atlanta metros. The BSN Pre-Licensure program student body decreased from 2,382 to 1,960 year-over-year or 422 students as a result of the enrollment stoppage in the Phoenix metro.

The chart below shows the breakdown by university nursing students versus total students.

A graph accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/79c649e9-5ac4-482e-801a-8da366ec7457

Liquidity

At April 30, 2022, the Company had unrestricted cash of $6.5 million and restricted cash of $6.4 million. Cash used in operations for the year ended April 30, 2022 was $11.3 million. Approximately $1.0 million of the cash used in operations is attributed to our Adjusted EBITDA loss, and the remaining use of operating cash is primarily attributed to increased working capital to support the growth in our monthly payment plans. Additionally, cash used in investing activities for the fiscal year ended April 30, 2022 was $4.2 million. To fund cash used in operations and investing activities, the Company issued $10.0 million of convertible debt and obtained a $20.0 million revolving credit facility.

As previously reported, the Company entered into a Consent Agreement on April 22, 2022 with the Arizona State Board of Nursing, and the Company was subsequently required to obtain an $18.3 million surety bond for the State of Arizona. The Company was required to restrict $5.0 million of cash and reserve its $20.0 million revolving credit facility as collateral for the surety bond. During fiscal Q4 2022, the Company reduced marketing spend, which ensured adequate liquidity to provide collateral for the surety bond. At this time, the Company is currently considering various growth and financing alternatives. Consequently, the Company plans to provide guidance and a financing update for the full fiscal year 2023 at our next earnings call in September.

Conference Call

Aspen Group, Inc. will host a conference call to discuss its fourth quarter and full year fiscal year 2022 results and business outlook on Tuesday, July 19, 2022, at 4:30 pm ET. Aspen Group, Inc. will issue a press release reporting results after the market closes on that day. The conference call can be accessed by dialing toll-free (877) 704-4453 (U.S.) or (201) 389-0920 (International), passcode 13730629.

Subsequent to the call, a transcript of the audio cast will be available from the Company's website at www.aspu.com. There will also be a seven-day dial-in replay which can be accessed by dialing toll-free (844) 512-2921 (U.S.) or (412) 317-6671 (International), passcode 13730629.

Non-GAAP – Financial Measures

This press release includes both financial measures in accordance with Generally Accepted Accounting Principles, or GAAP, as well as non-GAAP financial measures. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flows that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP financial measures should be viewed as supplemental to and should not be considered as alternatives to net income (loss), operating income (loss), and cash flow from operating activities, liquidity or any other financial measures. They may not be indicative of the historical operating results of AGI, nor are they intended to be predictive of potential future results. Investors should not consider non-GAAP financial measures in isolation or as substitutes for performance measures calculated in accordance with GAAP.

Our management uses and relies on EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin, which are non-GAAP financial measures. We believe that management, analysts, and shareholders benefit from referring to the following non-GAAP financial measures to evaluate and assess our core operating results from period-to-period after removing the impact of items that affect comparability. Our management recognizes that the non-GAAP financial measures have inherent limitations because of the excluded items described below.

We have included a reconciliation of our non-GAAP financial measures to the most comparable financial measures calculated in accordance with GAAP. We believe that providing the non-GAAP financial measures, together with the reconciliation to GAAP, helps investors make comparisons between AGI and other companies. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to the specific definition being used and to the reconciliation between such measure and the corresponding GAAP measure provided by each company under applicable SEC rules.

AGI defines Adjusted EBITDA as EBITDA excluding (1) bad debt expense, (2) stock-based compensation, and (3) non-recurring charges. The following table presents a reconciliation of net loss to EBITDA and Adjusted EBITDA and of net income (loss) margin to the Adjusted EBITDA margin:

	Three Months Ended April 30,								For the Years Ended April 30,
		2022				2021				2022				2021
Net loss	$	(2,128,638	)		$	(2,319,986	)		$	(9,585,781	)		$	(10,448,973	)
Interest expense, net		364,884				13,369				715,722				2,031,545
Taxes		38,880				(12,446	)			427,400				32,644
Depreciation and amortization		890,228				874,111				3,370,407				2,426,365
EBITDA		(834,646	)			(1,444,952	)			(5,072,252	)			(5,958,419	)
Bad debt expense		450,000				566,540				1,500,000				2,268,540
Stock-based compensation		569,098				382,936				2,534,665				2,203,822
Non-recurring charges - Other stock-based compensation		—				555,321				—				1,754,263
Non-recurring charges - Severance		—				303,870				19,665				347,870
Non-recurring charges - Other		339,025				275,438				(6,031	)			650,875
Adjusted EBITDA	$	523,477			$	639,153			$	(1,023,953	)		$	1,266,951
Net loss Margin		(11	)%			(12	)%			(12	)%			(15	)%
Adjusted EBITDA Margin		3	%			3	%			(1	)%			2	%

The following tables present a reconciliation of net loss to EBITDA and Adjusted EBITDA and of net income (loss) margin to the Adjusted EBITDA margin by business unit:

		Three Months Ended April 30, 2022
		Consolidated					AGI Corporate				AU				USU
Net income (loss)		$	(2,128,638		)		$	(4,991,258	)		$	1,534,709			$	1,327,911
Interest expense, net			364,884					364,906				—				(22	)
Taxes			38,880					20,600				(22,920	)			41,200
Depreciation and amortization			890,228					61,115				726,283				102,830
EBITDA			(834,646		)			(4,544,637	)			2,238,072				1,471,919
Bad debt expense			450,000					—				225,000				225,000
Stock-based compensation			569,098					500,077				51,207				17,814
Non-recurring charges - Other stock-based compensation			—					—				—				—
Non-recurring charges - Severance			—					—				—				—
Non-recurring charges - Other			339,025					339,025				—				—
Adjusted EBITDA		$	523,477				$	(3,705,535	)		$	2,514,279			$	1,714,733
Net loss Margin			(11		)%			NM				12	%			20	%
Adjusted EBITDA Margin			3		%			NM				20	%			26	%

_____________________

NM – Not meaningful

	Three Months Ended April 30, 2021
	Consolidated				AGI Corporate				AU				USU
Net income (loss)	$	(2,319,986	)		$	(4,736,579	)		$	1,388,800			$	1,027,793
Interest expense, net		13,369				13,486				—				(117	)
Taxes		(12,446	)			(14,250	)			2,064				(260	)
Depreciation and amortization		874,111				15,691				786,135				72,285
EBITDA		(1,444,952	)			(4,721,652	)			2,176,999				1,099,701
Bad debt expense		566,540				—				340,000				226,540
Stock-based compensation		382,936				275,938				75,605				31,393
Non-recurring charges - Other stock-based compensation		555,321				555,321				—				—
Non-recurring charges - Severance		303,870				303,870				—				—
Non-recurring charges - Other		275,438				239,438				36,000				—
Adjusted EBITDA	$	639,153			$	(3,347,085	)		$	2,628,604			$	1,357,634
Net loss Margin		(12	)%			NM				10	%			18	%
Adjusted EBITDA Margin		3	%			NM				20	%			24	%

	Year Ended April 30, 2022
	Consolidated				AGI Corporate				AU					USU
Net income (loss)	$	(9,585,781	)		$	(19,529,107	)		$	6,140,416				$	3,802,910
Interest expense, net		715,722				718,099				(1,739	)				(638	)
Taxes		427,400				23,963				360,947					42,490
Depreciation and amortization		3,370,407				177,835				2,809,255					383,317
EBITDA		(5,072,252	)			(18,609,210	)			9,308,879					4,228,079
Bad debt expense		1,500,000				—				950,000					550,000
Stock-based compensation		2,534,665				2,232,489				200,980					101,196
Non-recurring charges - Other stock-based compensation		—				—				—					—
Non-recurring charges - Severance		19,665				—				—					19,665
Non-recurring charges - Other		(6,031	)			446,660				(452,691	)				—
Adjusted EBITDA	$	(1,023,953	)		$	(15,930,061	)		$	10,007,168				$	4,898,940
Net loss Margin		(12	)%			NM				12	%				15	%
Adjusted EBITDA Margin		(1	)%			NM				19	%				20	%

	Year Ended April 30, 2021
	Consolidated				AGI Corporate				AU			USU
Net income (loss)	$	(10,448,973	)		$	(20,666,448	)		$	7,281,693		$	2,935,782
Interest expense, net		2,031,545				2,031,745				—			(200	)
Taxes		32,644				—				32,644			—
Depreciation and amortization		2,426,365				57,713				2,210,166			158,486
EBITDA		(5,958,419	)			(18,576,990	)			9,524,503			3,094,068
Bad debt expense		2,268,540				—				1,862,000			406,540
Stock-based compensation		2,203,822				1,845,683				210,771			147,368
Non-recurring charges - Other stock-based compensation		1,754,263				1,754,263				—			—
Non-recurring charges - Severance		347,870				347,870				—			—
Non-recurring charges - Other		650,875				614,875				36,000			—
Adjusted EBITDA	$	1,266,951			$	(14,014,299	)		$	11,633,274		$	3,647,976
Net loss Margin		(15	)%			NM				15	%		15	%
Adjusted EBITDA Margin		2	%			NM				24	%		18	%

Definitions

Lifetime Value ("LTV") – is calculated as the weighted average total amount of tuition and fees paid by every new student that enrolls in the Company's universities, after giving effect to attrition.

Bookings – is defined by multiplying LTV by new student enrollments for each operating unit.

Average Revenue per Enrollment ("ARPU") – is defined by dividing total bookings by total enrollments.

Adjusted EBITDA Margin – is defined as Adjusted EBITDA divided by revenue. We believe Adjusted EBITDA Margin is useful for management, analysts and investors as this measure allows for a more meaningful comparison between our performance and that of our competitors. Adjusted EBITDA Margin has certain limitations in that it does not take into account the impact to our consolidated statement of operations of certain expenses.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including the expected leverage and ability to improve operating results, programs fueling future growth, monthly payment plan growth, trends in the nursing industry, and our estimates as to Lifetime Value, bookings and ARPU. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Important factors that could cause actual results to differ from those in the forward-looking statements include the continued demand of nursing students for the new programs, student attrition, national and local economic factors including the labor market shortages, future NCLEX scores of our students, the failure to obtain approval from the National Council for State Authorization Reciprocity Agreements, competition from nursing schools in local markets, the competitive impact from the trend of major non-profit universities using online education and consolidation among our competitors. Other risks are included in our filings with the SEC including our Form 10-K for the year ended April 30, 2021, as amended by the Form 10-Q for the nine months ended January 31, 2022. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

About Aspen Group, Inc.

Aspen Group, Inc. is an education technology holding company that leverages its infrastructure and expertise to allow its two universities, Aspen University and United States University, to deliver on the vision of making college affordable again.

Investor Relations Contact

Kim Rogers

Managing Director

Hayden IR

385-831-7337 

[email protected]

GAAP Financial Statements

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

	April 30,
		2022				2021
Assets
Current assets:
Cash and cash equivalents	$	6,482,750			$	12,472,082
Restricted cash		6,433,397				1,193,997
Accounts receivable, net of allowance of $3,460,288 and $3,289,816, respectively		24,359,241				16,724,744
Prepaid expenses		1,358,635				1,077,831
Other current assets		748,568				68,529
Total current assets		39,382,591				31,537,183
Property and equipment:
Computer equipment and hardware		1,516,475				956,463
Furniture and fixtures		2,193,261				1,705,101
Leasehold improvements		7,179,896				5,729,324
Instructional equipment		715,652				421,039
Software		10,285,096				8,488,635
Construction in progress		2,100				247,767
		21,892,480				17,548,329
Accumulated depreciation and amortization		(8,395,001	)			(4,892,987	)
Property and equipment, net		13,497,479				12,655,342
Goodwill		5,011,432				5,011,432
Intangible assets, net		7,900,000				7,908,360
Courseware, net		274,047				187,296
Accounts receivable, net of allowance of $0, and $625,963, respectively		—				45,329
Long-term contractual accounts receivable		11,406,525				10,249,833
Deferred financing costs		369,902				18,056
Operating lease right-of-use assets, net		12,645,950				12,714,863
Deposits and other assets		578,125				479,212
Total assets	$	91,066,051			$	80,806,906

(Continued)

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (CONTINUED)

	April 30,
		2022				2021
Liabilities and Stockholders' Equity
Liabilities:
Current liabilities:
Accounts payable	$	1,893,287			$	1,466,488
Accrued expenses		2,821,432				2,040,896
Deferred revenue		5,889,911				6,825,014
Due to students		4,063,811				2,747,484
Operating lease obligations, current portion		2,036,570				2,029,821
Other current liabilities		130,262				307,921
Total current liabilities		16,835,273				15,417,624
Long-term debt, net		14,875,735				—
Operating lease obligations, less current portion		16,809,319				16,298,808
Total liabilities		48,520,327				31,716,432
Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.001 par value; 1,000,000 shares authorized,
0 issued and 0 outstanding at April 30, 2022 and April 30, 2021		—				—
Common stock, $0.001 par value; 60,000,000 shares authorized,
25,357,764 issued and 25,202,278 outstanding at April 30, 2022
25,066,297 issued and 24,910,811 outstanding at April 30, 2021		25,358				25,067
Additional paid-in capital		112,081,564				109,040,824
Treasury stock (155,486 and 155,486 shares, respectively)		(1,817,414	)			(1,817,414	)
Accumulated deficit		(67,743,784	)			(58,158,003	)
Total stockholders' equity		42,545,724				49,090,474
Total liabilities and stockholders' equity	$	91,066,051			$	80,806,906

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

	Years Ended April 30,
		2022				2021
Revenue	$	76,694,366			$	67,812,520
Operating expenses:
Cost of revenues (exclusive of depreciation and amortization shown separately below)		35,259,281				29,453,733
General and administrative		45,535,001				41,908,030
Bad debt expense		1,500,000				2,268,540
Depreciation and amortization		3,370,407				2,426,365
Total operating expenses		85,664,689				76,056,668
Operating loss		(8,970,323	)			(8,244,148	)
Other income (expense):
Interest expense		(718,786	)			(2,051,381	)
Other income (expense), net		530,728				(120,800	)
Total other expense, net		(188,058	)			(2,172,181	)
Loss before income taxes		(9,158,381	)			(10,416,329	)
Income tax expense		427,400				32,644
Net loss	$	(9,585,781	)		$	(10,448,973	)
Net loss per share - basic and diluted	$	(0.38	)		$	(0.44	)
Weighted average number of common shares outstanding - basic and diluted		25,016,437				23,757,656

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

	Years Ended April 30,
		2022				2021
Cash flows from operating activities:
Net loss	$	(9,585,781	)		$	(10,448,973	)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Bad debt expense		1,500,000				2,268,540
Depreciation and amortization		3,370,407				2,426,365
Stock-based compensation		2,534,665				3,958,085
Amortization of warrant-based cost		59,832				36,500
Amortization of deferred financing costs		114,751				164,362
Amortization of debt discounts		—				1,550,854
Loss on asset disposition		36,443				—
Non-cash lease benefit		(230,416	)			(27,796	)
Tenant improvement allowances received from landlords		816,591				4,685,826
Modification charge for warrants exercised		—				25,966
Common stock issued for services		—				19,900
Changes in operating assets and liabilities:
Accounts receivable		(9,203,042	)			(8,215,190	)
Prepaid expenses		(280,804	)			(136,160	)
Other receivables		—				23,097
Other current assets		(680,039	)			104,561
Accounts receivable, secured		45,329				—
Deposits and other assets		(98,913	)			(164,341	)
Accounts payable		426,799				(39,371	)
Accrued expenses		780,536				1,140,253
Due to students		858,010				375,640
Deferred revenue		(1,564,934	)			3,112,020
Other current liabilities		(177,659	)			125,440
Net cash (used in) provided by operating activities		(11,278,225	)			985,578
Cash flows from investing activities:
Purchase of finite life intangible assets		—				(8,500	)
Purchases of courseware and accreditation		(167,061	)			(120,408	)
Purchases of property and equipment		(4,160,318	)			(8,848,395	)
Net cash used in investing activities		(4,327,379	)			(8,977,303	)
Cash flows from financing activities:
Proceeds from drawdown on Credit Facility		5,000,000				—
Proceeds from 2022 Convertible Notes		10,000,000				—
Payments of deferred financing costs		(335,362	)			—
Proceeds from warrants exercised		—				1,081,792
Proceeds from stock options exercised		191,034				2,669,247
Net cash provided by financing activities		14,855,672				3,751,039

(Continued)

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

	Years Ended April 30,
		2022				2021
Net decrease in cash and cash equivalents	$	(749,932	)		$	(4,240,686	)
Cash, cash equivalents and restricted cash at beginning of year		13,666,079				17,906,765
Cash, cash equivalents and restricted cash at end of year	$	12,916,147			$	13,666,079
Supplemental disclosure cash flow information:
Cash paid for interest	$	470,895			$	310,958
Cash paid for income taxes	$	27,400			$	57,208
Supplemental disclosure of non-cash investing and financing activities:
Warrants issued as part of revolving credit facility	$	137,500			$	—
Warrants issued as surety bond consideration	$	118,000			$	—
Common stock issued for conversion of Convertible Notes	$	—			$	10,000,000

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheet that sum to the same such amounts shown in the consolidated statement of cash flows:

	April 30,
		2022				2021
Cash and cash equivalents	$	6,482,750			$	12,472,082
Restricted cash		6,433,397				1,193,997
Total cash and cash equivalents and restricted cash	$	12,916,147			$	13,666,079